• Ozanimod Lessens Inflammation in Crohn’s, Early Phase 2 Trial Data Show
  • Newly Funded Projects Aim to Improve Vaccine Use, Preventive Care in IBD
  • Program to Examine Gut Microbiota’s Role in Predicting Response to Therapies
  • First Patient Dosed in Phase 2b/3 Study of TD-1473 for Ulcerative Colitis
  • Plant-based Fasting-Mimicking Diet May Help Lessen IBD Severity
  • Aerobic and Strength Exercise Benefits IBD Patients in Remission, Phase 2 Trial Finds
  • Gene Mutations May Predict Risk of IBD Treatments’ Side Effects
  • Cell Therapy for Crohn’s Disease Fares Well in Preclinical Study; Clinical Trial is Next
  • Humira Safe and Effective for up to Six Years in Crohn’s Disease Patients, Study Shows
  • FDA Accepts Koutif Therapeutics’ Investigational New Drug Application for KT-1002
  • Humira Reduces Early Ulcerative Colitis Features, Trial Analysis Shows
  • IBD Patients Have More DNA Damage in Lymphocytes, Less Vitamin B6, Study Reports